122 related articles for article (PubMed ID: 6581867)
1. Response of non-T, non-B acute lymphocytic leukemia cells to phorbol ester.
Okamura J; Gelfand EW; Letarte M
Cancer Res; 1984 Mar; 44(3):1246-51. PubMed ID: 6581867
[TBL] [Abstract][Full Text] [Related]
2. Phorbol ester-induced differentiation of a non-T/non-B human leukemic cell line (REH) to macrophage-like cells.
Srivastava BI; Koga M; Srivastava P
Cancer Res; 1984 Jul; 44(7):3017-21. PubMed ID: 6373000
[TBL] [Abstract][Full Text] [Related]
3. 12-O-tetradecanoylphorbol-13-acetate actions on macromolecular synthesis, ornithine decarboxylase, and cellular differentiation of the rat embryonic visceral yolk sac in culture.
Huber BE; Brown NA
Cancer Res; 1983 Nov; 43(11):5552-9. PubMed ID: 6193876
[TBL] [Abstract][Full Text] [Related]
4. Phorbol ester-induced differentiation of a non-T, non-B leukemic cell line: model for human lymphoid progenitor cell development.
LeBien TW; Bollum FJ; Yasmineh WG; Kersey JH
J Immunol; 1982 Mar; 128(3):1316-20. PubMed ID: 7035564
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic modulation of chronic lymphocytic leukemia cells by phorbol ester: induction of IgM secretion and changes in the expression of B cell-associated surface antigens.
Gordon J; Mellstedt H; Aman P; Biberfeld P; Klein G
J Immunol; 1984 Jan; 132(1):541-7. PubMed ID: 6606672
[TBL] [Abstract][Full Text] [Related]
6. Modulation of chronic lymphocytic leukemia cells by phorbol ester: increase in Ia expression, IgM secretion and MLR stimulatory capacity.
Okamura J; Letarte M; Stein LD; Sigal NH; Gelfand EW
J Immunol; 1982 May; 128(5):2276-80. PubMed ID: 6460820
[TBL] [Abstract][Full Text] [Related]
7. Different stages of B cell differentiation in non-T acute lymphoblastic leukemia.
Foa R; Migone N; Saitta M; Fierro MT; Giubellino MC; Lusso P; Cordero di Montezemolo L; Miniero R; Lauria F
J Clin Invest; 1984 Nov; 74(5):1756-63. PubMed ID: 6438157
[TBL] [Abstract][Full Text] [Related]
8. Distinctive phorbol ester-induced morphological and surface antigen changes in mycosis fungoides, the Sézary syndrome, and adult T-cell leukemia.
Kadin ME; Nasu K; Sako D; Su IJ
Cancer Res; 1984 Aug; 44(8):3383-7. PubMed ID: 6611200
[TBL] [Abstract][Full Text] [Related]
9. Phorbol ester-induced differentiation of chronic B lymphocytic leukaemia cells--regulatory impact of autologous and allogeneic accessory cells.
Danersund A; Tötterman TH; Nilsson K; Egle-Jansson I; Kabelitz D; Sjöberg O
Clin Exp Immunol; 1985 Mar; 59(3):644-52. PubMed ID: 3872753
[TBL] [Abstract][Full Text] [Related]
10. Alterations in cell surface phenotype of T- and B-cell chronic lymphocytic leukemia cells following in vitro differentiation by phorbol ester.
Shawler DL; Glassy MC; Wormsley SB; Royston I
J Natl Cancer Inst; 1984 May; 72(5):1059-63. PubMed ID: 6609264
[TBL] [Abstract][Full Text] [Related]
11. Phorbol ester-induced differentiation of human T-lymphoblastic cell line HPB-ALL.
Nakao Y; Matsuda S; Fujita T; Watanabe S; Morikawa S; Saida T; Ito Y
Cancer Res; 1982 Sep; 42(9):3843-50. PubMed ID: 6179612
[TBL] [Abstract][Full Text] [Related]
12. Analysis of human promyelocytic leukemia cell (HL60) variants insensitive to phorbol ester tumor promoters.
Mascioli DW; Estensen RD
Cancer Res; 1984 Aug; 44(8):3280-5. PubMed ID: 6331641
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody MCS-2 as the marker of phorbol diester-induced myeloid differentiation in acute undifferentiated leukemia.
Gregg SL; Gajl-Peczalska KJ; LeBien TW; Bloomfield CD; Brunning R; Sagawa K
Cancer Res; 1984 Jun; 44(6):2724-30. PubMed ID: 6372996
[TBL] [Abstract][Full Text] [Related]
14. Enhanced expression of human Ia antigens by chronic lymphocytic leukemia cells following treatment with 12-O-tetradecanoylphorbol-13-acetate.
Guy K; Van Heyningen V; Dewar E; Steel CM
Eur J Immunol; 1983 Feb; 13(2):156-9. PubMed ID: 6403357
[TBL] [Abstract][Full Text] [Related]
15. Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester.
Tsuchiya S; Kobayashi Y; Goto Y; Okumura H; Nakae S; Konno T; Tada K
Cancer Res; 1982 Apr; 42(4):1530-6. PubMed ID: 6949641
[TBL] [Abstract][Full Text] [Related]
16. Induction of human malignant T-lymphoblastic cell lines MOLT-3 and jurkat by 12-O-tetradecanoylphorbol-13-acetate: biochemical, physical, and morphological characterization.
Nagasawa K; Howatson A; Mak TW
J Cell Physiol; 1981 Oct; 109(1):181-92. PubMed ID: 6976970
[TBL] [Abstract][Full Text] [Related]
17. Phorbol ester induction of plasmacytoid and hairy cell leukemia features in B-type lymphocytic leukemias: the relation to B-cell differentiation and maturation.
Gazitt Y; Polliack A
Blood Cells; 1987; 12(2):413-39. PubMed ID: 3497682
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of DNA synthesis and sugar uptake and lack of induction of ornithine decarboxylase in human epidermal cells treated with mouse skin tumor promoters.
Chida K; Kuroki T
Cancer Res; 1984 Mar; 44(3):875-9. PubMed ID: 6692409
[TBL] [Abstract][Full Text] [Related]
19. Regulation of CD9 expression during 12-O-tetradecanoyl-phorbol-13-acetate- induced differentiation of human myeloid leukemia (HL-60) cells.
Xu M; Chen L; Christman JK
Cell Growth Differ; 1994 Nov; 5(11):1225-34. PubMed ID: 7848923
[TBL] [Abstract][Full Text] [Related]
20. Phorbol ester (TPA)-induced surface membrane alterations in B-type hairy cell and lymphocytic leukemia cells.
Polliack A; Gurfel D; Leizerowitz R; Feinstein H; Gazitt Y
Scan Electron Microsc; 1986; (Pt 4):1523-35. PubMed ID: 3810025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
